6 Review of guidance

6 Review of guidance

6.1 The guidance on this technology will be considered for review 3 years after publication of the guidance. The Guidance Executive will decide whether the technology should be reviewed based on information gathered by NICE, and in consultation with consultees and commentators. However, if the follow up safety trials requested by the EMA publish within this time, the guidance will be reviewed sooner.

Andrew Dillon
Chief Executive
July 2015

  • National Institute for Health and Care Excellence (NICE)